International Society for Infectious Diseases

A global nonprofit society advancing infectious disease research, education, and outbreak response, best known for running ProMED early warning surveillance and the IJID journal family in service of worldwide public health.

5named by ISID
87named by peers

Financial profile

International Society for Infectious Diseases · EIN 22-2473000 · 501(c)(3)

Fiscal yearTotal revenueContributionsProgram servicesTotal expensesNet assetsYear end
FY2023$3,333,521$2,060,988$457,824$2,864,856$2,229,621Dec 2023
FY2022$2,861,337$656,607$1,722,381$4,101,295$1,761,861Dec 2022
FY2021$2,195,925$1,294,679$0$3,277,028$3,148,336Dec 2021
FY2020$3,298,662$2,919,994$0$2,931,939$4,389,371Dec 2020
FY2019$3,054,906$2,819,213$0$2,189,371$3,824,749Dec 2019
FY2018$2,830,341$1,934,428$655,629$3,620,485$2,861,145Dec 2018

Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.

Something wrong here? Tell us what we missed.

Peer societies

Five societies International Society for Infectious Diseases is read alongside.

Who backs ISID

Every company International Society for Infectious Diseases names publicly as a supporter, exactly as published. Companies also named by other associations on Sociogene come first.

CompanySupport as publishedAlso named by
TakedaSymposium SponsorAND AAAAI AAD AAFP AAN +3
Tropical Medicine and Infectious Disease (TropicalMed)Media PartnerACS AAR APHA ASV ASHG +3
Bavarian NordicSymposium SponsorAMGA APA ASTMH IDSA
MSDSymposium SponsorIASLC WSPID
TouchINFECTIOUS DISEASESMedia PartnerOnly International Society for Infectious Diseases, so far
Sources: 2 published lists, read September 2026

ICID 2026 Industry Supported Sessions timetable. Read September 27, 2026. Companies holding industry-supported sessions at ICID 2026 (Madrid). The Confirmed Sponsors & Exhibitors page loaded no list.

ICID 2026 partners. Read September 27, 2026. Media partners only; partner societies and congresses left out. TropicalMed recorded under its publisher MDPI, as named on the page.

Something wrong here? Tell us what we missed.

Who backs International Society for Infectious Diseases's peers, but not International Society for Infectious Diseases

Companies named publicly by at least one of International Society for Infectious Diseases's five peer societies, and not found in International Society for Infectious Diseases's reviewed public records.

CompanyIDSAWSPIDNFIDPeers
AstraZenecaNamedNamedDiamond3 of 3
PfizerNamedNamedDiamond3 of 3
Sanofi GlobalNamedNamedDiamond3 of 3
GSKNamedDiamond2 of 3
Initiative on behalf of Merck & Co.NamedGold2 of 3
ModernaTX, Inc.NamedGold2 of 3
AbbVieNamed1 of 3
Access TeleCareNamed1 of 3
Acurx PharmaceuticalsNamed1 of 3
ADMA BiologicsNamed1 of 3
ALKNamed1 of 3
AllucentNamed1 of 3
Associates of Cape Cod, Inc.Named1 of 3
Astellas Pharma Us, Inc.Named1 of 3
BiocodexNamed1 of 3
bioMérieuxNamed1 of 3
bioMerieux, Inc.Named1 of 3
BrukerNamed1 of 3
BugSeq BioinformaticsNamed1 of 3
CarecubesNamed1 of 3
Clarametyx BiosciencesNamed1 of 3
CorMedix TherapeuticsNamed1 of 3
CS MedicalNamed1 of 3
CSL SeqirusSilver1 of 3
Cumberland Pharmaceuticals now Apotex Corp.Named1 of 3
DanaherNamed1 of 3
DCN DxNamed1 of 3
Decera Clinical EducationNamed1 of 3
deepull diagnosticsNamed1 of 3
Delve BioNamed1 of 3
DiasorinNamed1 of 3
Enanta PharmaNamed1 of 3
Eolas MedicalNamed1 of 3
Eton PharmaceuticalsNamed1 of 3
Eurofins ViracorNamed1 of 3
F2GNamed1 of 3
Ferring Pharmaceuticals IncNamed1 of 3
Gilead Medical AffairsNamed1 of 3
Gotham BiotechNamed1 of 3
Hardy DiagnosticsNamed1 of 3
Healgen ScientificNamed1 of 3
Healix Infusion TherapyNamed1 of 3
IMMYNamed1 of 3
ImpriMedNamed1 of 3
Infectious Disease Special EditionNamed1 of 3
Infinity Bio Inc.Named1 of 3
Innoviva Specialty TherapeuticsNamed1 of 3
InsmedNamed1 of 3
InvivydNamed1 of 3
KariusNamed1 of 3
LabcorpNamed1 of 3
LifeAire SystemsNamed1 of 3
Med Learning GroupNamed1 of 3
Meitheal Pharmaceuticals, IncNamed1 of 3
MicroGenDxNamed1 of 3
MiraVista DiagnosticsNamed1 of 3
Mirum PharmaceuticalsNamed1 of 3
Nestlé Health Science I US PharmaceuticalsNamed1 of 3
NGD Infection PreventionNamed1 of 3
NovavaxSilver1 of 3
NozinNamed1 of 3
OraSure TechnologiesNamed1 of 3
Paratek PharmaceuticalsNamed1 of 3
Pattern BioscienceNamed1 of 3
Photon MedicsNamed1 of 3
PLEXISION,INCNamed1 of 3
Q-lineaNamed1 of 3
QuidelOrthoNamed1 of 3
Research Study RockstarNamed1 of 3
Roche DiagnosticsNamed1 of 3
Sanford GuideNamed1 of 3
Scanogen Inc.Named1 of 3
Second Life DiagnosticsNamed1 of 3
SeqDiagnostics, Inc.Named1 of 3
Shionogi Inc.Named1 of 3
Solu Healthcare OyNamed1 of 3
Splashblocker, LLCNamed1 of 3
Springer NatureNamed1 of 3
Takeda PharmaceuticalsNamed1 of 3
TECHLABNamed1 of 3
Theiagen Consulting LLCNamed1 of 3
Total TrialsNamed1 of 3
VaxcyteNamed1 of 3
Veloxis Pharmaceuticals, Inc.Named1 of 3
ViiV HealthcareNamed1 of 3
WockhardtNamed1 of 3
Wondfo USA Co LtdNamed1 of 3

Something wrong here? Tell us what we missed.

The outside view

A global nonprofit society advancing infectious disease research, education, and outbreak response, best known for running ProMED early warning surveillance and the IJID journal family in service of worldwide public health.

  • Consensus
  • Build
  • Outward
  • Operational

Their shape

The Republic

Run by its members, built to outlast them.

The Republic runs like a well-built institution, professional and stable, under the guidance of its members. Its gift is scale and continuity, its challenge is staying close to the grassroots as it grows.

Also reads toward The Movement, The Guild and The League.

Strengths

→Member voice and public mission stay in healthy balance.
→Open to reform without losing its footing.
→Speaks credibly on behalf of a whole field.

Not an official page of International Society for Infectious Diseases. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.